Hiramoto, Brent
Zalewski, Angelika
Gregory, Dyanna
Yang, Guang-Yu
Ho, Nancy
Gonsalves, Nirmala
Hirano, Ikuo https://orcid.org/0000-0001-7688-9377
Article History
Received: 12 January 2021
Accepted: 29 May 2021
First Online: 30 June 2021
Declarations
:
: The authors declare that there are no conflicts of interest in the publication of this article.
: Ikuo Hirano has served as a consultant for Adare, Allakos, Arena, AstraZeneca, EsoCap, Gossamer, Receptos, Regeneron, and Shire Pharmaceuticals. He has received research funding from Adare, Allakos, Receptos, Regeneron, and Shire. Nirmala Gonsalves has served on the advisory board and as a co-investigator for Allakos Inc. She has received royalties from Up to Date.
: For this type of study, formal consent is not required.